Verastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, announced the appointment of Matthew E. Ros as...
Colossal Biosciences, the world’s first de-extinction company, has announced $200M in a Series C financing by TWG Global, a diversified holding company with operating...
Neomorph, Inc., announced the appointment of Dr. Klaus Wagner as Chief Medical Officer. Dr. Wagner is a seasoned biotech executive with extensive experience in...
Bioptimus, the pioneering AI foundation model company, announced that it has reached a significant funding milestone of $76 million. This total includes a $41...
